Empirical Asset Management’s Genocea Biosciences, Inc. GNCA Stock Holding History

Empirical Asset Management’s Portfolio GNCA Stock Details GNCA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-10,000	Closed	–	–	183
2022 Q2	$0	Hold	10,000	–	–	﹤0.01%	183
2022 Q1	$13K	Hold	10,000	–	–	0.01%	145
2021 Q4	$12K	Buy	+10,000	New	+$14.9K	0.01%	150

Other funds holding GNCA

AICPI

ABG Innovation Capital Partners III Central, Hong Kong, Hong Kong $64.5K AUM 1.01% 1-Year Est. Return

Empirical Asset Management's GNCA Position: Q3 2022 in Review

Empirical Asset Management sold out of Genocea Biosciences, Inc. (GNCA) in Q3 2022, closing a stake of 10,000 shares.

Empirical Asset Management first reported a position in GNCA in Q4 2021 and held it in 3 quarters. The position peaked at $13K in Q1 2022. 1 fund tracked by Wall St. Rank holds GNCA as of Q3 2022.

Empirical Asset Management reported no remaining Genocea Biosciences, Inc. position as of Q3 2022 after selling out during the quarter.
Empirical Asset Management sold 10,000 Genocea Biosciences, Inc. shares in Q3 2022.
Empirical Asset Management first reported a position in Genocea Biosciences, Inc. in Q4 2021 and held it in 3 quarters.
Empirical Asset Management's Genocea Biosciences, Inc. position peaked at $13K in Q1 2022.
1 fund tracked by Wall St. Rank held Genocea Biosciences, Inc. as of Q3 2022.

Based on Empirical Asset Management's 13F filing for Q3 2022, filed 19 Oct 2022.